Market Cap ₹27 Cr.
Stock P/E
P/B 1.2
Current Price ₹19
Book Value ₹ 16.3
Face Value 10
52W High ₹30.5
Dividend Yield 0%
52W Low ₹ 18.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 17 | 12 | 11 | 12 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 17 | 12 | 11 | 12 | |
| Total Expenditure | 16 | 11 | 10 | 10 | |
| Operating Profit | 1 | 1 | 1 | 3 | |
| Interest | 0 | 0 | 1 | 1 | |
| Depreciation | 0 | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 0 | 0 | 0 | 2 | |
| Provision for Tax | 0 | 0 | 0 | 1 | |
| Profit After Tax | 0 | 0 | 0 | 1 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 0 | 0 | 1 | |
| Adjusted Earnings Per Share | 0.2 | 0.1 | 0 | 1.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 9% | -11% | 0% | 0% |
| Operating Profit CAGR | 200% | 44% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 14% | 5% | 5% | 5% |
| ROCE Average | 17% | 9% | 8% | 8% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 7 | 7 | 7 | 11 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 1 | 1 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 7 | 5 | 5 | 7 |
| Total Liabilities | 14 | 14 | 14 | 18 |
| Fixed Assets | 2 | 2 | 2 | 2 |
| Other Non-Current Assets | 0 | 0 | 0 | 3 |
| Total Current Assets | 12 | 12 | 12 | 13 |
| Total Assets | 14 | 14 | 14 | 18 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -1 | -1 | 0 | -2 |
| Cash Flow from Investing Activities | -0 | 0 | 0 | -0 |
| Cash Flow from Financing Activities | 2 | 1 | -0 | 2 |
| Net Cash Inflow / Outflow | 0 | -0 | -0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.2 | 0.15 | 0.04 | 1.25 |
| CEPS(Rs) | 0.57 | 0.46 | 0.31 | 1.42 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 8.78 | 8.92 | 8.97 | 10.73 |
| Core EBITDA Margin(%) | 5.35 | 7.12 | 6.83 | 20.9 |
| EBIT Margin(%) | 3.56 | 5.15 | 4.91 | 19.74 |
| Pre Tax Margin(%) | 1.15 | 1.38 | 0.4 | 14.47 |
| PAT Margin (%) | 0.96 | 1.04 | 0.3 | 10.11 |
| Cash Profit Margin (%) | 2.82 | 3.23 | 2.25 | 11.47 |
| ROA(%) | 1.16 | 0.87 | 0.24 | 7.97 |
| ROE(%) | 2.24 | 1.66 | 0.46 | 13.78 |
| ROCE(%) | 5.09 | 4.89 | 4.31 | 17.17 |
| Receivable days | 157.81 | 232.34 | 251.12 | 261.76 |
| Inventory Days | 45.8 | 65.02 | 70.75 | 46.88 |
| Payable days | 49.49 | 54.06 | 30.01 | 46.59 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.46 | 0.75 | 0.76 | 1.21 |
| EV/Core EBITDA(x) | 8.53 | 10.19 | 11.12 | 5.72 |
| Net Sales Growth(%) | 0 | -30.32 | -4.27 | 9.79 |
| EBIT Growth(%) | 0 | 0.73 | -8.7 | 341.26 |
| PAT Growth(%) | 0 | -25.22 | -72.3 | 3605.36 |
| EPS Growth(%) | 0 | -25.22 | -72.32 | 2974.45 |
| Debt/Equity(x) | 0.63 | 0.75 | 0.72 | 0.46 |
| Current Ratio(x) | 1.76 | 2.19 | 2.22 | 2.04 |
| Quick Ratio(x) | 1.45 | 1.82 | 1.79 | 1.91 |
| Interest Cover(x) | 1.48 | 1.36 | 1.09 | 3.75 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 64.52 | 64.52 |
| FII | 0 | 0 |
| DII | 0 | 0 |
| Public | 35.48 | 35.48 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 0.9 | 0.9 |
| FII | 0 | 0 |
| DII | 0 | 0 |
| Public | 0.5 | 0.5 |
| Others | 0 | 0 |
| Total | 1.4 | 1.4 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
